| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.4 | 2e-14 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.23 | 3e-09 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.22 | 1e-07 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-06 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.26 | 4e-06 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-05 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.17 | 2e-05 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.14 | 7e-05 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.14 | 8e-05 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0001 |